About
Junewicz & Co. was founded in 1990 by J. Mark Junewicz to provide focused, senior-level financial advisory services to small and mid-cap Life Sciences companies. Mark was previously a Managing Director in investment banking at Merrill Lynch and Bear Stearns. At Merrill Lynch, he was a senior investment banker for companies such as Schering-Plough, IBM, Time-Warner, Deere and other Fortune 500 clients. Mark was responsible for over 200 successful M&A and financing transactions.
Junewicz & Co. is focused on providing private investment banking services for public and private companies in the Life Sciences Industry including:
Key services include a range of M&A, business and strategic development, and licensing advisory services and assisting companies in raising equity capital. We provide independent, unconflicted advice. On both M&A and financing assignments, the capability of an advisor to run a focused, professional and thorough process aimed at the right target audience is critical to its success. Junewicz & Co. is highly experienced and has a successful track record in this area.
Junewicz & Co. has represented Life Sciences companies in the U.S., Europe and the Pacific Rim ranging in size from start-ups to public companies with market caps of over $4 billion. A number of former Junewicz & Co. clients have achieved successful exits for their shareholders. Unlike most boutiques, Junewicz & Co. focuses on a limited number of transactions at any time. It provides deep Life Sciences Industry knowledge with “bulge bracket” transaction skills. It is relationship-oriented with a “hands on” approach.
The firm has extensive relationships in the Life Sciences Industry with:
Junewicz & Co. is focused on providing private investment banking services for public and private companies in the Life Sciences Industry including:
- Biotechnology
- Specialty Pharmaceuticals
- Generics Drugs
- Medical Devices and Diagnostics
- Pharma Services
Key services include a range of M&A, business and strategic development, and licensing advisory services and assisting companies in raising equity capital. We provide independent, unconflicted advice. On both M&A and financing assignments, the capability of an advisor to run a focused, professional and thorough process aimed at the right target audience is critical to its success. Junewicz & Co. is highly experienced and has a successful track record in this area.
Junewicz & Co. has represented Life Sciences companies in the U.S., Europe and the Pacific Rim ranging in size from start-ups to public companies with market caps of over $4 billion. A number of former Junewicz & Co. clients have achieved successful exits for their shareholders. Unlike most boutiques, Junewicz & Co. focuses on a limited number of transactions at any time. It provides deep Life Sciences Industry knowledge with “bulge bracket” transaction skills. It is relationship-oriented with a “hands on” approach.
The firm has extensive relationships in the Life Sciences Industry with:
- Senior managements, board members and business development officers at biotech, pharma and medical device companies;
- Leading venture capital and private equity investors; and
- Other investment bankers, lawyers and consultants specializing in the industry.